Treatment of chalazia by incision and curettage versus intralesional triamcinolone acetonide injection

---

Original Article

Author Details : Sirisha Brundavanam, Ramya Deepthi, Kumar Amruth*

Volume : 5, Issue : 3, Year : 2019

Article Page : 133-135

https://doi.org/10.18231/j.ijooo.2019.034

Suggest article by email

Get Permission

---

Abstract

Purpose: To compare the outcomes of treatment of primary chalazion with intralesional Triamcinolone Acetonide (TA) and Incision & Curettage(I&C) in patients with failed conservative treatment.
Materials and Methods
Study Design: Prospective randomized study
Place and Duration: The study was conducted from November 2017 to January 2019 in The Department of Ophthalmology, Narayana medical college, and Hospital, Nellore.
Methodology: 40 patients with primary chalazia who, after failed conservative treatment were randomized to either intralesional TA injection (4 mg) or I&C performed under local anesthesia. Preoperative photograph of the lesion was taken. Complete resolution was considered as lesion regression of 95% to 100%. Treatment was considered a failure if no resolution was achieved after the first attempted I&C or TA injection. Lesion resolution measured as 95% to 100% regression.
Results: Out of 40 patients, 20 were randomized to I&C and 20 to TA injection group. Complete resolution was achieved in 16 cases in the I&C group and 17cases in TA group. The average time of resolution in TA group was four days. No significant complications were noted in either of the groups.
Conclusions: Intralesional TA injection is as effective as I&C in cases of primary chalazia. So, injection may be considered as an alternative first-line treatment in cases where no biopsy is required.
 

Keywords: Chalazion, Incision & curettage, Triamcinolone acetonide, Transconjunctival approach, Resolution

How to cite : Brundavanam S, Deepthi R, Amruth K, Treatment of chalazia by incision and curettage versus intralesional triamcinolone acetonide injection. IP Int J Ocul Oncol Oculoplasty 2019;5(3):133-135

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.